Olaparib and anifrolumab added to PBS The treatments for breast cancer and lupus have now been added to the scheme, alongside medicines for leukaemia and insomnia.
Breast cancer detection delayed by COVID-19 The rate of metastatic breast cancer doubled after breast screening programs shut down during the pandemic.
Lack of safety data prompts guidance on oestrogen therapy A summary of evidence is out for prescribing oestrogen treatments for the estimated 75% of breast cancer patients who develop genitourinary symptoms.
Should the breast screening age be lowered? While the question has again been put forward, Australian experts remain unconvinced, saying participation among target groups is more important.
How can Australia increase BreastScreen participation? With more than one in two eligible women not taking part in the preventive screening program, the RACGP has suggested ways to boost engagement.
Feminist language being hijacked to market medical tests Narratives around empowerment and women’s rights are being co-opted to market interventions not backed by evidence, according to new research.
Make breast density reporting mandatory: RANZCR The radiologist body is calling for an expansion of mammogram services, and a GP expert agrees it will help patients make more informed choices.
Study calls for population-wide genomic screening Expanded testing for three genetic conditions could save lives and money, Monash University research suggests.
Cancer screening may not extend life: Study But a more personalised approach that matches screening recommendations to individual risk profiles may help overcome existing shortcomings.
Trial highlights lack of awareness on alcohol and breast cancer link But an Australian study looking at the effectiveness of alcohol intervention targeting women has shown promise for change.